Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to better understand the potential scope of our support.

From the week of November 4th, we are planning to work on 14 projects, including:

Reimbursement

1. Delivering the reimbursement analysis project for novel IVD technologies intended for early diagnostics and management of cancer in England, France, Germany, Italy, and Spain
2. Working on the reimbursement analysis project for local treatment of bladder cancer in England
3. Working on reimbursement and procedure volume analysis project for multiple technologies in obstetrics and gynecology in France, Germany, Italy, and Spain
4. Delivering materials for a live virtual educational seminar on market access challenges in Europe for one of the leading med tech companies in Europe
5. Working on policy analysis project, including qualitative interviews, in the obstetrics and gynecology field in Austria, Denmark, Finland, Norway and Sweden 
6. Delivering the reimbursement strategy project for four peripheral vascular technologies in Italy and Poland
7. Working on the reimbursement strategy project for several technologies in ophthalmological, urological, and oncological fields in the Nordic region (Denmark, Finland, Norway, and Sweden)
8. Working on the reimbursement analysis project for several cardiovascular and peripheral vascular technologies in Norway

HEOR

1. Working on the development of an HTA national submission dossier in Sweden
2. Working on the development of a health economic model for neurovascular technology in Belgium, England, France, Germany, Italy, and Spain
3. Working on the update of adaptation of the global value dossiers for several technologies in cardio-renal and infectious disease space to European settings 
4. Working on adaptations of the health economic model for in-vitro diagnostic tests in infectious disease areas in France and Spain
5. Working on the development of a health economic model for neuromonitoring technology in England
6. Initiating the development of a health economic model for in-vitro diagnostic tests in neurology disease area in England, France, Germany, Italy, and Spain

Let us know if you need any market access or HEOR support for your medical technology in Europe.